Company Filing History:
Years Active: 2022
Title: Frada Berenshteyn: Innovator in Pharmaceutical Compounds
Introduction
Frada Berenshteyn is a notable inventor based in Woburn, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as inhibitors for specific biological processes.
Latest Patents
Frada Berenshteyn holds a patent for "6-6 fused bicyclic heteroaryl compounds and their use as LATS inhibitors." This invention relates to 6-6 Fused Bicyclic Heteroaryl Compounds of the Formula A2 or A1 and their use as LATS inhibitors, or a salt, stereoisomer, or pharmaceutical composition thereof. The invention also encompasses methods for LATS inhibition in a cell population using these compounds, as well as their therapeutic applications and manufacturing processes.
Career Highlights
Frada Berenshteyn is associated with Novartis AG, a leading global healthcare company. His work focuses on innovative solutions in the pharmaceutical industry, contributing to advancements in medical treatments.
Collaborations
He has collaborated with notable colleagues such as Dirk Behnke and Xueshi Hao, enhancing the research and development efforts within his field.
Conclusion
Frada Berenshteyn's contributions to pharmaceutical innovations highlight his role as a key inventor in the industry. His work continues to impact the development of therapeutic compounds and methods for treating various diseases.